However, in clinical trials targeting severe cognitive impairment, chronic fatigue syndrome, or neuropathy, therapeutic doses usually range from 1,500 mg to 3,000 mg (1.5g 3g) daily
The activity of specific PPARs has been implicated in the regulation of insulin sensitivity and symptoms of obesity (41, 42) as well as the control of food intake (43)
Patients report better control over blood sugar levels, reduced blood pressure, improved cholesterol profiles, and decreased markers of inflammation
DSIP also demonstrates neuroprotective effects, including antioxidant properties and stroke recovery benefits
Its also worth mentioning that Wegovy is only a part of a comprehensive weight management program
Rather than simply suppressing appetite, it recalibrates the brains response to food stimuli, lowering cravings and reducing the reward-driven urge to overeat